Blood tests are among the most common tools in medicine. Scientists are working to make blood cell imaging faster and more intuitive so that doctors can make fast and accurate diagnostic decisions.
The device has shown to be advantageous for individuals with neurological or orthopaedic disorders.
Researchers have created a new type of drug molecule that can precisely destroy TERRA, an RNA molecule that helps certain cancer cells survive. Using advanced “RIBOTAC” technology, their compound finds TERRA inside cells and breaks it down without harming healthy molecules. This discovery could pave the way for a new generation of RNA-based cancer treatments, targeting the disease at its genetic roots rather than just its symptoms.
For decades, scientists have thought they understood the biochemical machinery that causes asthma—inflammation in the lungs that constricts airways and makes it hard to breathe.
Melbourne scientists have revealed how hydrogen is made and used in the human gut. Though infamous for making flatulence ignite, hydrogen also has a positive role supporting gut health.
Two teams of researchers have developed a cell reprogramming technology that converts rogue disease-causing T cells from our immune system into protective Tregcells. These cells help ensure that the immune system doesn’t attack the body’s own tissues. The breakthroughs could usher in more personalized and targeted cell therapies for a host of autoimmune diseases.
YORK, S.C., Oct. 23, 2025 /PRNewswire/ — Elkem ASA (ticker: ELK), a global leader in advanced silicon-based materials, today unveiled SILBIONE™ LSR Select EC 70, a next-generation medical-grade liquid silicone rubber. Designed for wearable and diagnostic devices, the material combines high electrical conductivity, certified biocompatibility1, and enhanced process control, setting a new standard for precision healthcare applications.
Researchers at the Icahn School of Medicine at Mount Sinai and their collaborators have developed a new technology to track beneficial bacteria after fecal microbiota transplants (FMT). The approach provides a detailed view of how donor microbes take hold and persist in the patients’ gut—not only which bacteria successfully colonized but how they change over time.
Today’s GPS smartwatches and other wearable devices give millions of runners reams of data about their pace, location, heart rate and more. But one thing your Garmin can’t measure is plain old physics: How much force is being generated when your foot hits the ground and takes off again.
A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for cancer in their lymph nodes—a finding that could guide treatment decisions and help many people avoid lymph node biopsy surgery. The study results are published in JAMA Surgery.